首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Screening for possible miRNA–mRNA associations in a colon cancer cell line
Authors:Sotaro Kanematsu  Kousuke Tanimoto  Yutaka Suzuki  Sumio Sugano
Institution:1. Graduate School of Frontier Sciences, University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8562, Japan;2. Genome Laboratory, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan
Abstract:MicroRNAs (miRNAs) are small non-coding RNAs mediating the regulation of gene expression in various biological contexts, including carcinogenesis. Here, we screened putative associations between 34, 45, and 103 miRNAs and 164, 391, and 81 mRNAs via Argonaute1 (Ago1) or Ago2 immunoprecipitation (IP) experiments in a colon cancer cell line. We used a combination of RIP Seq analysis. RNAs that were co-immunoprecipitated with Ago1 or Ago2 were used for massively parallel small RNA and mRNA sequencing. The detected miRNAs and mRNAs were further associated with one another based on in silico target predictions. Analysis of the putative associations indicated that, although Ago1 and Ago2 shared a similar repertory of miRNAs, the mRNAs possibly regulated by those miRNAs seemed different. The mRNAs detected with Ago1 IP were indicated to be frequently associated with genes having constitutive cellular functions, regulated by a smaller number of miRNAs, and appeared to receive more stringent translational regulation. In contrast, putative miRNA-mRNA associations detected with Ago2 IP appeared to be related to signal transduction genes, which had a larger number of possible miRNA binding sites. We then conducted a similar analysis using the colon cancer cells cultured under hypoxia and identified potential hypoxia-induced miRNA-mRNA associations, which included several well-characterized cancer-related genes as novel putative miRNA targets.
Keywords:Ago  Argonaute  BCL2  B-cell CLL/lymphoma 2  BIM  BCL2-interacting mediator of cell death  miRNPs  miRNA-silencing effector protein complexes  VEGF  vascular endothelial growth factor  HIF1A  hypoxia inducible factor 1 alpha subunit  HMGA2  high mobility group AT-hook 2  RPLP2  ribosomal protein large P2  HIC2  hypermethylated in cancer 2  TSC  tuberous sclerosis  mTOR  mechanistic target of rapamycin  CAMKK2  calcium/calmodulin-dependent protein kinase kinase 2  DACT1  dapper  antagonist of beta-catenin homolog 1  ATRX  alpha thalassemia/mental retardation syndrome X-linked
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号